Notícias e Atividades da Magnolia Medical Technologies
Executivos
Veja o organograma con seus 15 executivos principais
Biografias mais buscadas da Magnolia Medical Technologies
- Jason Richey, President and Chief Executive Officer
- Marc-André Marcotte, Director
- Paul Enever, Director
Recentes movimentos de executivos em Magnolia Medical Technologies
- Sarah Huber, ingressou na Companhia como Senior Vice President, Sales (Notícia publicada em 13 de fevereiro de 2026).
- Dean Shute, Manager, Manufacturing Engineering, deixou a Companhia (Notícia publicada em 30 de janeiro de 2026).
Criar um alerta
para seguir os movimentos de executivos da Magnolia Medical Technologies.
Biotecnologia
Magnolia Medical Technologies possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).
Popular M&A news in Biotecnologia
- Ona Therapeutics acaba de anunciar uma arrecadação de fundos de 87 milhões de dólares. (publicado em 5 de junho de 2026).
- Laboratoire Servier has announced the acquisition of Edgewise Therapeutics (publicado em 4 de junho de 2026).
- Oak Hill Bio acaba de anunciar uma arrecadação de fundos de 33 milhões de dólares. (publicado em 4 de junho de 2026).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Magnolia Medical Technologies
- News & Media - Magnolia Medical
- Magnolia Medical Launches New Magnolia Analytics™ Service to Streamline Data Capture and Quantify the Clinical & Cost Effectiveness of Preventing Sepsis Misdiagnosis - Magnolia Medical
- News & Media - Magnolia Medical
- News & Media - Magnolia Medical
- In Recognition of Sepsis Awareness Month, Magnolia Medical Intensifies Efforts to Combat the Clinical and Economic Risks of Sepsis Misdiagnosis - Magnolia Medical
- Magnolia Medical Expands Steripath® Micro Initial Specimen Diversion Device® (ISDD®) Product Family with New FDA 510(k) Clearance - Magnolia Medical
- The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure Copy - Magnolia Medical
- The National Quality Forum (NQF) Endorses Centers for Disease Control and Prevention’s (CDC) New Blood Culture Contamination Quality Measure - Magnolia Medical
- Large-scale, peer-reviewed study quantifies multiple devastating patient harms associated with blood culture contamination and most significantly, a 74% increase in risk of in-hospital patient mortality - Magnolia Medical
- Stanford Health Care Achieves Zero Blood Culture Contaminations and Near Elimination of False-Positive CLABSIs in Large-Scale Study Using the Steripath® Initial Specimen Diversion Device® - Magnolia Medical
- View more press releases Close
Redes sociais sobre Magnolia Medical Technologies
- Magnolia Medical Technologies na Wikipedia, Google News e Yahoo Finance
- Magnolia Medical Technologies na LinkedIn, X (Twitter) e YouTube
